Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
National Center for Immunization and Respiratory Diseases · National Center for Emerging and Zoonotic Infectious Diseases · +4 more institutions
Abstract
THIS REPORT UPDATES THE 2021-22 RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) CONCERNING THE USE OF SEASONAL INFLUENZA VACCINES IN THE UNITED STATES: (MMWR Recomm Rep 2021;70[No. RR-5]:1-24). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. With the exception of vaccination for adults aged ≥65 years, ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. All seasonal influenza vaccines expected to be available in the United States for the 2022-23…
Citation impact
- FWCI
- 45.31
- Percentile
- 100%
- References
- 113
Authors
8- LALisa A. GrohskopfCorresponding
National Center for Immunization and Respiratory Diseases
- LBLenee Blanton
National Center for Immunization and Respiratory Diseases
- JMJill M. Ferdinands
National Center for Immunization and Respiratory Diseases
- JRJessie R. Chung
National Center for Immunization and Respiratory Diseases
- KRKaren R. Broder
National Center for Emerging and Zoonotic Infectious Diseases
Topics & keywords
- Advisory committee
- Seasonal influenza
- Immunization
- Live attenuated influenza vaccine
- Influenza season
- Disease control
- Medicine
- Virology
- Good health and well-being